Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Antengene Corporation Limited ( (HK:6996) ) has issued an announcement.
Antengene Corporation Limited has announced a board meeting scheduled for August 22, 2025, to review and approve the interim financial results for the first half of the year. This meeting is significant for stakeholders as it will provide insights into the company’s financial health and operational performance, potentially impacting its market positioning and investor confidence.
The most recent analyst rating on (HK:6996) stock is a Hold with a HK$1.06 price target. To see the full list of analyst forecasts on Antengene Corporation Limited stock, see the HK:6996 Stock Forecast page.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company focused on innovative oncology therapies. The company is incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange.
YTD Price Performance: 684.62%
Average Trading Volume: 5,862,254
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.23B
For an in-depth examination of 6996 stock, go to TipRanks’ Overview page.